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Over the recent years, considerable progress has been
made in elucidating processes that are critical for thyr-
oid hormone (TH) synthesis and action. In this issue of
Thyroid Research several German groups dedicated to
thyroid research have assembled and discussed novel
aspects of thyroid hormone action with the perspective
to improve diagnosis and therapy of thyroid disorders
by better understanding disturbed thyroid differentia-
tion. The over-arching theme addressed in the contribu-
tions of this special issue relates to the main focus of
current thyroid research and treatment of thyroid dise-
sase, i.e. “What defines thyroid health?” [1]. Thereby the
putative role of seemingly established players in TH
synthesis and action are revisited.
A report on a patient characterized by a novel germ-
line TSH-receptor mutation links this case of non-auto-
immune hyperthyroidism to new impliations in TSH-
receptor structure [2]. The study highlights the impor-
tance of introducing novel diagnostic approaches to the
clinics, because this particular mutation in the TSH-
receptor is correlated to altered Gq-signalling pathways,
thereby pointing to an important role of Gq signalling
in the thyroid
It is known only since recently that transport of TH is
an active and regulated mechanism. The monocarboxy-
late transporter 8 (MCT8) is a crucially important trans-
porter of TH and it transports triiodothyronine (T3)
specifically well. Mutations in MCT8 are known to
cause a severe syndrome of X-linked mental retardation
known as Allan-Herndon Dudley syndrome. Based on
homology modeling all of the currently reported patho-
genic mutations in MCT8 are studied in the article by
Kleinau et al. [3]. A focus is set on identification of
those MCT8 mutations that are most sensitive for sub-
strate transport with the goal to simulate in silico the
potencies of future therapies based on TH transporter-
specific inhibitors mimicking TH structurally.
Besides MCT8 other transporters have been proposed
to play important roles in TH transport (MCT10,
OATP1C1, OATP1A2, OATP14, LAT1 and LAT2). The
structure-function relationships of primary TH transpor-
ters like MCT8 and additional, so-called secondary TH
transporters such as those listed above is reviewed by
Kinne et al. [4] with special attention on their expres-
sion profiles, transport specificities and substrates. Simi-
larities and differences in structure and molecular
features of the known and suspected TH transporters
are compared between man and mouse, in particular
asking their crucial impact on TH actions in the central
nervous system.
TH actions in the brain and clinical consequences of
non-classical, rather novel treatment protocols to relieve
symptoms of severe mood and depression disorders is
reviewed in the article by Pilhatsch et al. [5].
For a long time, only genomic actions of TH, namely
of T3 were recognized by both, thyroid researchers and
clinicians. However this picture has to be revised as
non-classical, non-genomic TH actions were described
which lead to activation of alternative signaling path-
ways via PI3K and MAPK. The impact and perspectives
of these recent findings are summarized by Möller and
Bröcker-Preuß [6] who comment on the outcomes of
activation of alternative signaling pathways on transcrip-
tional regulation of TH target cells.
Non-classical and classical TH actions must be taken
into consideration for better management of thyroid
malignancies. Moreover, it is increasingly appreciated
that disturbances in TH synthesis occur in thyroid
tumorigenesis and that disturbed TH action affects car-
cinogenesis in general. Of the many novel aspects in
thyroid carcinogenesis, it was the recent identification of
miRNAs and their intricate involvement in the regula-
tion of transcriptional, translational and epigentic con-
trol mechanisms that provides one of the most
promising diagnostic and high-potential, future thera-
peutic tool. The aspects of miRNA relevance for thyroid
pathologies are discussed by Braun and Hüttelmaier [7].
Likewise, regulation of transcription and translation by
RNA binding proteins is addressed in the article by Tro-
janowicz et al. The adenylate uridylate-rich element
binding proteins AUF together with HuR was reported
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to regulate mRNA stability and could hence participate
in thyroid carcinogenesis. RNA binding proteins may
harbor multifunctional properties that not only affect
thyrocyte differentiation but could also affect TH synth-
esis [8].
Finally, the characterization of protein transport path-
ways and the identification of altered trafficking in thyr-
oid carcinoma cells are approached in the experimental
study by Tedelind et al. [9] that investigated the cathe-
psins which are known as thyroglobulin-processing
enzymes with important functions in TH biosynthesis.
We believe that the papers collected for this special
issue of Thyroid Research will have a stimulatory effect
not only for thyroid researchers but will be interesting
for those from associated disciplines.
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